SCHEMBL18019798

SCHEMBL18019798

O=C1CCC(C2CCC(Cl)CC2)N1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.38
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28222420 0.89
SCHEMBL26673240 0.80 SRD5A1 (0.38) SRD5A1
SCHEMBL3944528 0.79 SRD5A1 (0.35) SRD5A1
SCHEMBL3944336 0.79 SRD5A1 (0.35) SRD5A1
SCHEMBL9998683 0.78 SRD5A1 (0.37) SRD5A1
SCHEMBL18150856 0.78 SRD5A1 (0.37) SRD5A1
SCHEMBL18289470 0.77 SRD5A1 (0.43) SRD5A1GAA
SCHEMBL12534015 0.76 SRD5A1 (0.38) SRD5A1
SCHEMBL18151596 0.75 SRD5A1 (0.35) SRD5A1GAA
SCHEMBL5567030 0.74 ALDH1A1 (0.36) SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016128140-A1 PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER MERCK PATENT GMBH (DE) 2016-08-18 WO disclosed